纵横研报
Ticker Detail

600812.SHG

¥4.97+3.11% 华北制药 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
North China Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical, biological, agricultural, and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China.

MARKET 市值 7.91B CNY PE 51.2x Fwd 23.8x 52W ¥4.11 – ¥7.4 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -16.4% ROE 3.4% 营业利润率 5.9% 净利润率 1.8%
ANALYST 股息率 0.78%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制